logo-loader
viewCancer Genetics Incorporated

Cancer Genetics CEO 'excited about the vision and future' by being highly focused on drug discovery

Cancer Genetics, Inc (NASDAQ:CGIX) CEO Jay Roberts tells Proactive the drug discovery and preclinical oncology and immuno-oncology services provider says he's 'excited about the vision and future' of the firm by focusing more on drug discovery and by strengthening its balance sheet.

Roberts says the firm is well positioned to carry through new strategic alternative activities to further strengthen its position in the industry.

Quick facts: Cancer Genetics Incorporated

Price: 2.93 USD

NASDAQ:CGIX
Market: NASDAQ
Market Cap: $6.62 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

iCoreConnect cloud-based software is a real game changer in healthcare

iCoreConnect (OTCQB: ICCT) President and CEO Robert McDermott joined Steve Darling from Proactive to discuss the company that provides HIPAA-compliant software for the medical and dental industries. McDermott discusses a few of their services, their recent revenue growth and why listing on...

7 hours, 14 minutes ago

2 min read